Allergy News and Research

RSS

The term allergy encompasses a wide range of conditions; it is not a disease in itself. In 1906 Clemens von Pirquet was the first to describe allergies as a changed or altered reaction of the immune system in response to exposure to foreign proteins. These days the term allergy – medically termed hypersensitivity, signifies an exaggerated reaction to foreign substances.

Further study of past flu pandemics key to future preparedness

Scientists and public health officials, wary that the H5N1 avian influenza virus could trigger an influenza pandemic, have looked to past pandemics, including the 1918 "Spanish Flu," for insight into pandemic planning.

28 Feb 2007

Exposure to diesel exhaust during commutes poses a serious public health risk

The Boston-based environmental research group reported today that even though we spend only a tiny portion of our day commuting, it's during the commute that we receive more than half our overall exposure to deadly fine particle pollution.

28 Feb 2007

Male circumcision reduces men's HIV infection risk by 65%

Routine male circumcision could reduce a man's risk of HIV infection through heterosexual sex by 65%, according to final data from two NIH-funded studies conducted in Kenya and Uganda published in the Feb. 23 issue of the journal Lancet, the New York Times reports.

25 Feb 2007

Pharmaceutical companies overcharging federal health care programs

Pharmaceutical companies have been systematically overcharging federal health care programs, costing taxpayers billions of dollars, according to federal officials, members of Congress and an advocacy group, the Newhouse News/Richmond Times-Dispatch reports.

25 Feb 2007

Entire genetic blueprints of more than 2,000 human and avian influenza viruses completed and made public

The Influenza Genome Sequencing Project, funded by the National Institute of Allergy and Infectious Diseases (NIAID), announced today that it has achieved a major milestone.

21 Feb 2007

Newborns with respiratory distress should be evaluated for primary ciliary dyskinesia

Reviewing published reports, Ferkol and Margaret Leigh, M.D., professor of pediatrics at the University of North Carolina at Chapel Hill (UNC), found that neonatal respiratory distress was a common clinical symptom of PCD, a chronic airway disease that affects about 1 in 15,000 children.

20 Feb 2007

Scientists discover vulnerable area on HIV that could lead to development of HIV/AIDS vaccine

Scientists on Wednesday announced they had identified a vulnerable area on HIV that might be susceptible to antibodies and could prevent the virus from infecting human cells, Reuters Health reports. The findings are published in the Feb. 15 issue of the journal Nature.

19 Feb 2007

Seasonal flu vaccine offers some protection from H5N1

The yearly influenza vaccine that health officials urge people to get each fall might also offer certain individuals some cross protection against the H5N1 virus commonly known as bird flu, according to investigators at St. Jude Children's Research Hospital.

13 Feb 2007

Researchers discover why antipsychotic drugs cause weight gain

Researchers at Johns Hopkins University in Baltimore have discovered why some drugs used to treat mental illnesses such as schizophrenia, cause patients to gain a lot of weight.

13 Feb 2007

Healthier wines

A new technique that uses ozone to preserve grapes could help prevent allergies and boost healthy compounds at the same time, reports Jennifer Rohn in Chemistry & Industry, the magazine of the Society of Chemical Industry.

12 Feb 2007

FDA approves absorbable polymer suture that uses DNA technology

The U.S. Food and Drug Administration (FDA) has announced it has cleared for marketing in the U.S. the TephaFLEX Absorbable Suture - the first absorbable polymer suture made from material isolated from bacteria modified by recombinant DNA technology.

12 Feb 2007

South Africa starts major HIV/AIDS vaccine trial

The launch of the first large-scale study to evaluate a candidate HIV vaccine on the African continent was announced today by study collaborators in the United States and South Africa. The trial will involve up to 3,000 participants at five sites throughout South Africa and is expected to continue for four years.

11 Feb 2007

Hair dye allergies increasing

Allergic reactions to hair dye are increasing as more and younger people dye their hair, warn researchers in this week's British Medical Journal.

5 Feb 2007

Different treatments may be needed for chronic asthma, depending on whether it results from allergies or lung infections

Researchers have now identified a particular gene that influences how severe a M. pneumoniae infection may be, which in turn suggests that a different strategy might be needed for treating asthma resulting from this and similar lung infections rather than allergies.

31 Jan 2007

Cellular mechanism linked to inflammation and cancer

A team led by biochemists at the University of California, San Diego has found what could be a long-elusive mechanism through which inflammation can promote cancer. The findings may provide a new approach for developing cancer therapies.

28 Jan 2007

Human immune system has not adapted to changes in the environment

It seems that the current "allergy epidemic" is due not so much to an increase in allergenic risk factors as to the disappearance of factors protecting people against allergies.

25 Jan 2007

Inhaled steroids best treatment for children with asthma

Although several medications are available to help children maintain asthma control, clinical trials directly comparing them have not been conducted.

23 Jan 2007

Heska to sell allergy patents to Allergopharma

Heska Corporation has announced that it has completed the sale of its rights in a worldwide patent portfolio covering a number of major allergens and the genes that encode them to Allergopharma Joachim Ganzer KG for an undisclosed sum.

22 Jan 2007

Sequella receives FDA fast track status for pulmonary tuberculosis drug

Sequella, Inc. has announced it has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for SQ109, the company's proprietary lead drug candidate for treatment of pulmonary tuberculosis (TB).

22 Jan 2007

Lung neutrophils produce histamine in significant quantities

In a surprise finding, scientists have discovered that histamine, the inflammatory compound released during allergic reactions that causes runny nose, watery eyes, and wheezing, can be produced in large amounts in the lung by neutrophils, the white blood cells that are the major component of pus.

14 Jan 2007